Sep 23, 2021 / 04:00PM GMT
Operator
Good afternoon, and thank you for joining BioXcel's Virtual R&D Day. (Operator Instructions) As a reminder, this event is being recorded.
At this time, I would like to turn the call over to Frank Yocca, Chief Scientific Officer of BioXcel Therapeutics.
Frank D. Yocca - BioXcel Therapeutics, Inc. - Senior VP & Chief Scientific Officer
Thank you, operator. Good afternoon, everyone. I'm Frank Yocca, Chief Scientific Officer at BioXcel Therapeutics. Thank you for joining our virtual R&D Day. We are very excited to share some new developments today and how we are revolutionizing drug discovery and development through artificial intelligence. We will showcase our proprietary AI platform, discuss our emerging neuroscience pipeline candidates and update you on expansion opportunities for our lead program, BXCL501.
Slide 2, please. As a reminder, during today's presentation, we will be making forward-looking statements regarding our R&D plans. These statements are subject to risks and uncertainties that may cause actual results to
BioXcel Therapeutics Inc To Host Virtual R&D Day Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot